Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating dolastatin-10 in patients with metastatic prostate cancer that did not respond to prior hormone therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Dolastatin 10 (dolastatin-10)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED